Best Pot Stocks in 2024 Right Now

Here Are The Best 3 Marijuana Stocks To Watch Today

Marijuana stocks are still in a volatile place in the stock market. Yet this has played a part in why they can invest in the future of cannabis at low price points. Right now there is a lack of upward trading consistency for the sector. Meaning that most cannabis stocks can not sustain an upward position in the market. Often when there is a volatile rise in trading it is short-lived only seeing a recovery for just a few minutes even just moments.

Nevertheless, the cannabis industry is still evolving. With more progress and growth comes the motivation to become invested. That is why currently more people are looking for the best marijuana stocks to buy. Many are banking on the future success of the industry to yield their big gains. Yet like any other investment, you need to do your research and have a plan of action.

One of the things about how marijuana stocks trade is they can rise or fall without warning. This has also been a tough factor to account for which is why sometimes shareholders miss their chance to take profits. However with a new year soon to begin there may be more investment opportunities. The companies mentioned below are just a few marijuana stocks to watch in 2024.

Top Marijuana Stocks To Watch 2024

  1. Trulieve Cannabis Corp. (OTC:TCNNF)
  2. Cresco Labs Inc. (OTC:CRLBF)
  3. MariMed Inc. (OTC:MRMD)

Trulieve Cannabis Corp.

Trulieve Cannabis Corp. together with its subsidiaries, operates as a medical cannabis company. The company cultivates and produces products in-house and distributes its products to Trulieve branded stores (dispensaries) in Florida. As well as through home delivery. Recently the company reported its Q3 2023 financial results. marijuana stocks to watch trulieve (TRUL) (TCNNF)

Q3 2023 Financial and Operational Highlights

  • Revenue of $275 million, with 96% of revenue from retail sales.
  • Achieved GAAP gross margin of 52%, with gross profit of $143 million.
  • SG&A expenses lowered by $2 million sequentially to $94 million.
  • Reported net loss of $25 million. Adjusted net loss of $15 million* excludes non-recurring charges, disposals and discontinued operations.
  • Achieved EBITDA of $74 million*, or 27% of revenue and adjusted EBITDA of $78 million*, or 28% of revenue.
  • Purchased $57 million face value senior secured 2026 notes for USD $47.6 million in September, which represents a 16.5% discount to par, plus accrued interest.

[Read More] Top 3 Marijuana Penny Stocks to Watch Post-Thanksgiving

Cresco Labs Inc.

Cresco Labs Inc. together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. On November 15th the company reported their Q3 2023 financial results. Cresco Labs

Q3 2023 Highlights

  • Third quarter revenue of $191 million, with retail growth and strong performance in core markets helping to offset purposeful attrition from divested assets.
  • In comparison to Q1, when the Company initiated the Year-of-the-Core strategy, adjusted gross margin1 increased by over 480 bps, adjusted SG&A1 decreased by
  • $40 million on an annualized basis and adjusted EBITDA margin1 rose by over 1000 bps.
  • Generated $62 million in operating cash flow through the first nine months of the year.
  • Gross profit of $94 million, 49% of revenue.
  • Adjusted gross profit1 of $96 million and adjusted gross margin1 of 51%, up 373 bps from the second quarter.

[Read More] 3 Marijuana Stocks To Watch Over The Holidays

MariMed Inc.

MariMed Inc. engages in the cultivation, production, and dispensing of medicinal and recreational cannabis in the United States and internationally. MRMDIn recent news, the company closed $58.7 million in debt refinancing.

Words From The Company

“I am delighted to announce the closing of this debt refinancing, which will generate significant cash savings,” said Jon Levine, MariMed’s Chief Executive Officer. “Securing a lower rate, when interest rates continue to rise, is the result of the financial discipline we have displayed over the past decade. Importantly, we are pleased there is no warrant or other equity component resulting in dilution to our shareholders.”

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 |
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like